REFERENCES
1. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res 2020;24:91-8.
2. Morawska L, Cao J. Airborne transmission of SARS-CoV-2: The world should face the reality. Environ Int 2020;139:105730.
3. Li R, Pei S, Chen B, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science 2020;368:489-93.
4. Byambasuren O, Cardona M, Bell K, Clark J, Mclaws M, Glasziou P. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: Systematic review and meta-analysis. JAMMI 2020;5:223-34.
5. Paixão B, Baroni L, Pedroso M, et al. Estimation of COVID-19 under-reporting in the Brazilian states through SARI. New Gener Comput 2021:1-23.
6. Prado MFD, Antunes BBDP, Bastos LDSL, et al. Analysis of COVID-19 under-reporting in Brazil. Rev Bras Ter Intensiva 2020:32.
7. Volpatto DT, Resende ACM, Anjos L, et al. Spreading of COVID-19 in Brazil: impacts and uncertainties in social distancing strategies. medRxiv 2020:20117283.
8. Walker PGT, Whittaker C, Watson OJ, et al. The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries. Science 2020;369:413-22.
10. Lloyd-Sherlock P, Ebrahim S, Geffen L, McKee M. Bearing the brunt of covid-19: older people in low and middle income countries. BMJ 2020;368:m1052.
11. Hallal PC, Hartwig FP, Horta BL, et al. SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys. Lancet Glob Health 2020;8:e1390-8.
12. . Arango, H. B. Theoretical and computational biostatistics. Rio de Janeiro: Guanabara-Koogan; 2001. p. 235. (in Portuguese)
13. Peeling RW, Wedderburn CJ, Garcia PJ, et al. Serology testing in the COVID-19 pandemic response. Lancet Infect Dis 2020;20:e245-9.
14. Winter AK, Hegde ST. The important role of serology for COVID-19 control. Lancet Infect Dis 2020;20:758-9.
15. Abbasi K. Covid-19: screening without scrutiny, spending taxpayers’ billions. BMJ 2020;371:m4487.
16. Cheng KJG, Sun Y, Monnat SM. COVID-19 Death Rates Are Higher in Rural Counties With Larger Shares of Blacks and Hispanics. J Rural Health 2020;36:602-8.
17. Silveira MF, Barros AJD, Horta BL, et al. Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil. Nat Med 2020;26:1196-9.
18. Moghadas SM, Fitzpatrick MC, Sah P, et al. The implications of silent transmission for the control of COVID-19 outbreaks. Proc Natl Acad Sci U S A 2020;117:17513-5.
19. Chan HF, Skali A, Savage DA, Stadelmann D, Torgler B. Risk attitudes and human mobility during the COVID-19 pandemic. Sci Rep 2020;10:19931.
20. Wang S, Liu Y, Hu T. Examining the Change of Human Mobility Adherent to Social Restriction Policies and Its Effect on COVID-19 Cases in Australia. Int J Environ Res Public Health 2020;17:7930.
21. Woolhandler S, Himmelstein DU, Ahmed S, et al. Public policy and health in the Trump era. Lancet 2021;397:705-53.
22. McCleskey J, Gruda D. Risk-taking, resilience, and state anxiety during the COVID-19 pandemic: a coming of (old) age story. Pers Individ Dif 2021;170:1-6.
24. Li W, Zhang B, Lu J, et al. Characteristics of household transmission of COVID-19. Clin Infect Dis 2020;71:1943-6.
25. Allen WE, Altae-Tran H, Briggs J, et al. Population-scale longitudinal mapping of COVID-19 symptoms, behaviour and testing. Nat Hum Behav 2020;4:972-82.
27. Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY) 2020;12:6049-57.
